semaglutide aki Frontiers Understanding Semaglutide: Medication, Digestive Health,

Wegovy is approved for chronic weight management in eligible adults with overweight or obesity

Because Semaglutide structurally optimizes your digestive and metabolic timelines, your gastrointestinal tract will undergo a normal adjustment period during the first few weeks

Plateaus are normal after 6-8 weeks as your body adapts, and often resolve with continued treatment or minor dose adjustments

Value in Health 27(6):S55S56 Kornelius E et al (2024) The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy

After taking other risk factors into account, the risk of first-time suicidal thoughts was 73% lower with Wegovy, the researchers said

Experimental data indicate increased functional tone of the lower esophageal and pyloric sphincters following peptide administration, a response associated with reduced reflux-related injury and attenuation of esophageal inflammation in animal models (11)